This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2019 Jul 6;394(10192):e1.

doi: 10.1016/S0140-6736(19)31519-3. Epub 2019 Jul 4.

No authors listed

Published Erratum

No authors listed. Lancet. 2019.

. 2019 Jul 6;394(10192):e1.

doi: 10.1016/S0140-6736(19)31519-3. Epub 2019 Jul 4.

No abstract available

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.
Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, Pedersen KB, Saugstrup T, Meier JJ; PIONEER 4 investigators. Pratley R, et al. Lancet. 2019 Jul 6;394(10192):39-50. doi: 10.1016/S0140-6736(19)31271-1. Epub 2019 Jun 8. Lancet. 2019. PMID: 31186120 Clinical Trial.